NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer

Journal of Clinical Investigation

Volumn 123, Issue 2, 2013, Pages 700-711

  Couturier Maillard, Aurélie ^a,b,c,d   Secher, Thomas ^c,j   Rehman, Ateequr ^e   Normand, Sylvain ^a,b,c,d   De Arcangelis, Adèle ^f   Haesler, Robert ^g   Huot, Ludovic ^a,b,c,d   Grandjean, Teddy ^a,b,c,d   Bressenot, Aude ^d   Delanoye Crespin, Anne ^a,b,c,d   Gaillot, Olivier ^a,b,c,d   Schreiber, Stefan ^g   Lemoine, Yves ^a,b,c,d   Ryffel, Bernhard ^c,h   Hot, David ^a,b,c,d   Nùñez, Gabriel ⁱ   Chen, Grace ⁱ   Rosenstiel, Philip ^g   Chamaillard, Mathias ^a,b,c,d  

^a UNIV LILLE   (France)

^b INSERM U1019   (France)

^c CNRS   (France)

^d INSERM   (France)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h UNIVERSITY OF CAPE TOWN   (South Africa)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j France   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CIPROFLOXACIN; DEXTRAN SULFATE; GENTAMICIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; NEUTRALIZING ANTIBODY; STREPTOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; BLOODY DIARRHEA; BONE MARROW CELL; CARCINOGENESIS; CELL MIGRATION; CELL MOTION; COLITIS; COLON MUCOSA; COLORECTAL CANCER; COMMUNICABLE DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISEASE TRANSMISSION; EPITHELIUM CELL; FECES MICROFLORA; FEMALE; GENOTYPE; GRANULOCYTE; HISTOLOGY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INTESTINE FLORA; MALE; MORBIDITY; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECTUM HEMORRHAGE; REMISSION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME; WEIGHT REDUCTION;

ANIMALS; COLITIS; COLORECTAL NEOPLASMS; DIGESTIVE SYSTEM; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; METAGENOME; MICE; MICE, KNOCKOUT; NOD2 SIGNALING ADAPTOR PROTEIN; PREGNANCY; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RISK FACTORS;

EID: 84873372079     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62236     Document Type: Article

References (53)

1. Arumugam M, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174-180.
2. Ley RE, et al. Evolution of mammals and their gut microbes. Science. 2008;320(5883):1647-1651.
3. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med. 2010;16(2):228-231.
4. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and inflammation in the intestine. Cell. 2010;140(6):859-870.
5. Kandori H, Hirayama K, Takeda M, Doi K. Histochemical, lectin-histochemical and morphometrical characteristics of intestinal goblet cells of germfree and conventional mice. Exp Anim. 1996;45(2):155-160.
6. Pabst O, et al. Adaptation of solitary intestinal lymphoid tissue in response to microbiota and chemokine receptor CCR7 signaling. J Immunol. 2006;177(10):6824-6832.
7. Atarashi K, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331(6015):337-341.
8. Asquith M, Powrie F. An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer. J Exp Med. 2010;207(8):1573-1577.
9. Scanlan PD, Shanahan F, O'Mahony C, Marchesi JR. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol. 2006;44(11):3980-3988.
10. Manichanh C, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55(2):205-211.
11. Joossens M, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut. 2011;60(5):631-637.
12. Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010;138(6):2101-2114.e5.
13. Hugot JP, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411(6837):599-603.
14. Hampe J, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet. 2001;357(9272):1925- 1928.
15. Ogura Y, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411(6837):603-606.
16. Watanabe T, et al. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest. 2008;118(2):545-559.
17. Kobayashi KS, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307(5710):731-734.
18. Geddes K, et al. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med. 2011;17(7):837-844.
19. Kim YG, Park JH, Shaw MH, Franchi L, Inohara N, Nunez G. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity. 2008;28(2):246-257.
20. Chamaillard M, Girardin SE, Viala J, Philpott DJ. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol. 2003;5(9):581-592.
21. Petnicki-Ocwieja T, et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A. 2009;106(37):15813-15818.
22. Rehman A, et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut. 2011;60(10):1354-1362.
23. Mondot S, et al. Altered gut microbiota composition in immune-impaired Nod2 (-/-) mice. Gut. 2012;61(4):634-635.
24. Frank DN, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17(1):179-184.
25. Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol. 2007;8(10):1086-1094.
26. Garrett WS, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007;131(1):33-45.
27. Lieu HT, et al. Reg2 inactivation increases sensitivity to Fas hepatotoxicity and delays liver regeneration post-hepatectomy in mice. Hepatology. 2006;44(6):1452-1464.
28. Pickert G, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206(7):1465-1472.
29. Feagins LA, Souza RF, Spechler SJ. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol. 2009;6(5):297-305.
30. Rosenstiel P, et al. Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol. 2006;8(7):1188-1198.
31. Mockelmann N, et al. Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer. BMC Gastroenterol. 2009;9:79.
32. Neufert C, Becker C, Neurath MF. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc. 2007;2(8):1998-2004.
33. Bollrath J, et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 2009;15(2):91-102.
34. Grivennikov S, et al. IL-6 and stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15(2):103-113.
35. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H. IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol. 2000;164(9):4878- 4882.
36. Elinav E, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145(5):745-757.
37. Hashimoto T, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477-481.
38. Zeissig S, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut. 2007;56(1):61-72.
39. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134(2):577-594.
40. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307(5717):1915-1920.
41. Bloom SM, et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe. 2011;9(5):390-403.
42. Secher T, Gaillot O, Ryffel B, Chamaillard M. Remote control of intestinal tumorigenesis by innate immunity. Cancer Res. 2010;70(5):1749-1752.
43. Olszak T, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336(6080):489-493.
44. Kurzawski G, et al. The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res. 2004;64(5):1604-1606.
45. Papaconstantinou I, et al. Association between mutations in the C ARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer. 2005;114(3):433-435.
46. Roberts RL, Gearry RB, Allington MD, Morrin HR, Robinson BA, Frizelle FA. Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. Cancer Res. 2006;66(5):2532-2535.
47. Yamamoto T, Umegae S, Kitagawa T, Matsumoto K. Mucosal cytokine production during remission after resection for Crohn's disease and its relationship to future relapse. Aliment Pharmacol Ther. 2004;19(6):671-678.
48. Atreya R, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med. 2000;6(5):583-588.
49. Jones SA, Scheller J, Rose-John S. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest. 2011;121(9):3375-3383.
50. Taga T, et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 1989;58(3):573-581.
51. Normand S, et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci U S A. 2011;108(23):9601-9606.
52. Tavazoie S, Hughes JD, Campbell MJ, Cho RJ, Church GM. Systematic determination of genetic network architecture. Nat Genet. 1999;22(3):281-285.
53. Weigmann B, Tubbe I, Seidel D, Nicolaev A, Becker C, Neurath MF. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc. 2007;2(10):2307-2311.